Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mesa Laboratories (MLAB) EBT: 2010-2025

Historic EBT for Mesa Laboratories (MLAB) over the last 16 years, with Sep 2025 value amounting to $2.0 million.

  • Mesa Laboratories' EBT fell 47.56% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year increase of 102.73%. This contributed to the annual value of $6.0 million for FY2025, which is 102.16% up from last year.
  • Mesa Laboratories' EBT amounted to $2.0 million in Q3 2025, which was down 71.49% from $7.0 million recorded in Q2 2025.
  • Mesa Laboratories' EBT's 5-year high stood at $7.0 million during Q2 2025, with a 5-year trough of -$275.3 million in Q1 2024.
  • Moreover, its 3-year median value for EBT was $461,000 (2025), whereas its average is -$23.7 million.
  • Its EBT has fluctuated over the past 5 years, first spiked by 1,981.54% in 2021, then tumbled by 99,297.83% in 2024.
  • Over the past 5 years, Mesa Laboratories' EBT (Quarterly) stood at -$2.3 million in 2021, then skyrocketed by 181.85% to $1.9 million in 2022, then climbed by 1.57% to $1.9 million in 2023, then crashed by 213.93% to -$2.2 million in 2024, then crashed by 47.56% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $7.0 million for Q2 2025, and $461,000 during Q1 2025.